ADUS
Price
$99.35
Change
+$0.49 (+0.50%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
1.68B
10 days until earnings call
CHE
Price
$546.64
Change
-$38.82 (-6.63%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
9.7B
89 days until earnings call
Ad is loading...

ADUS vs CHE

Header iconADUS vs CHE Comparison
Open Charts ADUS vs CHEBanner chart's image
Addus HomeCare
Price$99.35
Change+$0.49 (+0.50%)
Volume$619
Capitalization1.68B
Chemed
Price$546.64
Change-$38.82 (-6.63%)
Volume$1.4K
Capitalization9.7B
ADUS vs CHE Comparison Chart
Loading...
ADUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CHE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADUS vs. CHE commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADUS is a StrongBuy and CHE is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (ADUS: $98.88 vs. CHE: $546.78)
Brand notoriety: ADUS and CHE are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: ADUS: 59% vs. CHE: 205%
Market capitalization -- ADUS: $1.68B vs. CHE: $9.7B
ADUS [@Medical/Nursing Services] is valued at $1.68B. CHE’s [@Medical/Nursing Services] market capitalization is $9.7B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $88.21B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $4.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADUS’s FA Score shows that 0 FA rating(s) are green whileCHE’s FA Score has 1 green FA rating(s).

  • ADUS’s FA Score: 0 green, 5 red.
  • CHE’s FA Score: 1 green, 4 red.
According to our system of comparison, CHE is a better buy in the long-term than ADUS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADUS’s TA Score shows that 5 TA indicator(s) are bullish while CHE’s TA Score has 5 bullish TA indicator(s).

  • ADUS’s TA Score: 5 bullish, 4 bearish.
  • CHE’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, CHE is a better buy in the short-term than ADUS.

Price Growth

ADUS (@Medical/Nursing Services) experienced а -2.10% price change this week, while CHE (@Medical/Nursing Services) price change was -6.00% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +2.41%. For the same industry, the average monthly price growth was -2.56%, and the average quarterly price growth was +2.46%.

Reported Earning Dates

ADUS is expected to report earnings on Aug 04, 2025.

CHE is expected to report earnings on Jul 23, 2025.

Industries' Descriptions

@Medical/Nursing Services (+2.41% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CHE($9.7B) has a higher market cap than ADUS($1.68B). CHE has higher P/E ratio than ADUS: CHE (35.73) vs ADUS (26.94). CHE YTD gains are higher at: 3.300 vs. ADUS (-21.117). CHE has higher annual earnings (EBITDA): 414M vs. ADUS (107M). CHE has more cash in the bank: 264M vs. ADUS (64.8M). CHE has less debt than ADUS: CHE (155M) vs ADUS (175M). CHE has higher revenues than ADUS: CHE (2.26B) vs ADUS (1.06B).
ADUSCHEADUS / CHE
Capitalization1.68B9.7B17%
EBITDA107M414M26%
Gain YTD-21.1173.300-640%
P/E Ratio26.9435.7375%
Revenue1.06B2.26B47%
Total Cash64.8M264M25%
Total Debt175M155M113%
FUNDAMENTALS RATINGS
ADUS vs CHE: Fundamental Ratings
ADUS
CHE
OUTLOOK RATING
1..100
2725
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
87
Overvalued
PROFIT vs RISK RATING
1..100
5530
SMR RATING
1..100
7337
PRICE GROWTH RATING
1..100
5953
P/E GROWTH RATING
1..100
4961
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ADUS's Valuation (72) in the Medical Or Nursing Services industry is in the same range as CHE (87). This means that ADUS’s stock grew similarly to CHE’s over the last 12 months.

CHE's Profit vs Risk Rating (30) in the Medical Or Nursing Services industry is in the same range as ADUS (55). This means that CHE’s stock grew similarly to ADUS’s over the last 12 months.

CHE's SMR Rating (37) in the Medical Or Nursing Services industry is somewhat better than the same rating for ADUS (73). This means that CHE’s stock grew somewhat faster than ADUS’s over the last 12 months.

CHE's Price Growth Rating (53) in the Medical Or Nursing Services industry is in the same range as ADUS (59). This means that CHE’s stock grew similarly to ADUS’s over the last 12 months.

ADUS's P/E Growth Rating (49) in the Medical Or Nursing Services industry is in the same range as CHE (61). This means that ADUS’s stock grew similarly to CHE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ADUSCHE
RSI
ODDS (%)
Bullish Trend 2 days ago
59%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
52%
Momentum
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
57%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
44%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
46%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
63%
Bearish Trend 2 days ago
40%
Advances
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
52%
Declines
ODDS (%)
Bearish Trend 17 days ago
65%
Bearish Trend 9 days ago
46%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
65%
Bullish Trend 2 days ago
50%
Aroon
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
43%
View a ticker or compare two or three
Ad is loading...
ADUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CHE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SMH208.9710.06
+5.06%
VanEck Semiconductor ETF
JNUG70.332.85
+4.22%
Direxion Daily Jr Gld Mnrs Bull 2X ETF
QQXT92.161.30
+1.43%
First Trust NASDAQ-100 ex-Tech Sect ETF
VSMV47.340.46
+0.99%
VictoryShares US Mult-Fctr Mnmm Vltl ETF
ASHS27.59-0.11
-0.38%
Xtrackers Harvest CSI 500 CHN A SmCp ETF

ADUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADUS has been loosely correlated with SNDA. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ADUS jumps, then SNDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADUS
1D Price
Change %
ADUS100%
+0.86%
SNDA - ADUS
39%
Loosely correlated
+4.16%
PNTG - ADUS
38%
Loosely correlated
N/A
SEM - ADUS
38%
Loosely correlated
+2.71%
CHE - ADUS
35%
Loosely correlated
+1.03%
USPH - ADUS
35%
Loosely correlated
+1.30%
More